Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients

被引:109
|
作者
Lanchou, J [1 ]
Corbel, M
Tanguy, M
Germain, N
Boichot, E
Theret, N
Clement, B
Lagente, V
Malledant, Y
机构
[1] Univ Rennes, INSERM U456, Rennes, France
[2] CHU Rennes, Hop Pontchaillou, Serv Reanimat Chirurg, Rennes, France
关键词
matrix metalloproteinases; tissue inhibitor of matrix metalloproteinases; acute respiratory distress syndrome; acute lung injury;
D O I
10.1097/01.CCM.0000048626.02184.F8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Matrix metalloproteinases (MMPs) are known to be involved in degradation of extracellular matrix. We aimed to assess the role of MMPs and their natural inhibitors (TIMPs) in the genesis and the evolution of acute respiratory distress syndrome (ARDS). Design: Prospective, clinical study. Setting: Intensive care unit of a university hospital. Patients: Twenty-one patients were assigned to three different groups: Group 1 patients developed ARDS that rapidly resolved in <4 days; Group 2 patients developed ARDS lasting >8 days; Group 3 (control group) patients had clinical criteria for hospital-acquired pneumonia without ARDS. Intervention: Bronchoalveolar lavages were performed on day 0 of the onset of ARDS and on days 4, 8, and 12 for unresolving ARDS. For group 3, the bronchoalveolar lavages were performed on day 0 of the pneumonia. On these bronchoalveolar lavage fluids, we measured the amount of MMP-9 and -2 and their inhibitors TIMP-1 and -2. Measurements and Main Results: The amount of MMP-9 measured by enzyme-linked immunosorbent assay was significantly lower in the bronchoalveolar lavages from patients with ARDS (group 1 and group 2) compared with the control group (p < .01) throughout the study. The ratio MMP-9/TIMP-1 was also significantly smaller and was less than one in the two ARDS groups (p < .05) compared with the control group (group 3), where this ratio was greater than one. In the second bronchoalveolar lavages, this ratio was greater than one only in the ARDS group that rapidly resolved (group 1), whereas it stayed less than one when the ARDS was lasting (group 2). Concerning the quantity of MMP-2 and the ratio MMP-2/TIMP-2, there was no statistical difference between the three groups throughout the study. Using zymography, there was no significant difference in the amounts of active and latent MMP-9 between the three groups. Moreover, no significant difference in the quantity of latent and active MMP-2 in the three groups was noted. Conclusion: These results suggest that the MMP-9 level and MMP-9/TIMP-1 ratio play a role in the pathogenesis of ARDS and, namely, the imbalance between MMP-9 and TIMP-1 would participate in airway remodeling leading to either short- or long-course ARDS. The ratio MMP-9/TIMP-1 could be a predictive factor of the ARDS evolution.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 50 条
  • [32] Localization of MMP-2, MMP-9, TIMP-1, and TIMP-2 in human coronal dentine
    Niu, L. N.
    Zhang, L.
    Jiao, K.
    Li, F.
    Ding, Y. X.
    Wang, D. Y.
    Wang, M. Q.
    Tay, F. R.
    Chen, J. H.
    JOURNAL OF DENTISTRY, 2011, 39 (08) : 536 - 542
  • [33] Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis
    Jiang, Zhongxin
    Sui, Tao
    Wang, Bin
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (09) : 1219 - 1226
  • [34] Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis
    Yang, YN
    Bauer, D
    Wasmuth, S
    Steuhl, KP
    Heiligenhaus, A
    EXPERIMENTAL EYE RESEARCH, 2003, 77 (02) : 227 - 237
  • [35] Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis
    Zhongxin Jiang
    Tao Sui
    Bin Wang
    Rheumatology International, 2010, 30 : 1219 - 1226
  • [36] PLASMA LEVELS OF SERUM METALLOPROTEINASES MMP-9, MMP-2 AND TISSUE INHIBITORS TIMP-2 IN NEWBORNS WITH NECROTIZING ENTERO COLITIS
    Khvorostov, Igor
    Smirnov, Ivan
    ARCHIV EUROMEDICA, 2021, 11 (01): : 79 - 81
  • [37] Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid
    Kolb, SA
    Lahrtz, F
    Paul, R
    Leppert, D
    Nadal, D
    Pfister, HW
    Fontana, A
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 84 (02) : 143 - 150
  • [38] Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis
    Salata, Ireneusz M.
    Stojanovic, Nemanja
    Cajdler-Luba, Agata
    Lewandowski, Krzysztof C.
    Lewinski, Andrzej
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (06) : 326 - 330
  • [39] Expression of matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinases (TIMP-1) during PGF2α-induced luteolysis in sheep.
    Towle, TAT
    Tsang, PCW
    Milvae, RA
    Newbury, MK
    McCracken, JA
    BIOLOGY OF REPRODUCTION, 2000, 62 : 125 - 126
  • [40] MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis
    Giannelli, G
    Erriquez, R
    Iannone, F
    Marinosci, F
    Lapadula, G
    Antonaci, S
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (03) : 335 - 338